Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

FY26 FR0 DFS/PHL - IDT Sequencing Reagent

Active
State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract forecast pertains to the procurement of sequencing reagents for the Forensic Sciences Division of the District of Columbia, scheduled for fiscal year 2026. The solicitation is intended to support forensic DNA analysis operations, with the reagents critical to maintaining the accuracy and efficiency of sequencing workflows used in criminal investigations and evidence processing. Despite the lack of specific solicitation numbers, NAICS codes, or set-aside details, the anticipated procurement reflects an ongoing operational need within the agency’s forensic laboratory capabilities. The place of performance and point of contact information are currently unspecified, suggesting the details are still under development or will be finalized closer to the formal solicitation release. The posting date indicates the forecast is publicly available to potential vendors as an early notification ahead of a future bid opportunity, allowing suppliers to prepare proposals and align their offerings with the agency’s requirements.

General Info

Procurement of forensic DNA sequencing reagents for DC Forensic Sciences Division in fiscal year 2026.

Agency

District of Columbia → Forensic Sciences (DFS)

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDistrict of Columbia → Forensic Sciences (DFS)
ContactsNo contacts available
OfficeN/A
Organization / Agency
District of Columbia → Forensic Sciences (DFS)
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Sequencing Reagent

Similar Contracts

Same NAICS industry code

NAICS: 325413
New
SLED
FY26 FR0 DFS/PHL - Qiagen reagentsThe contract forecasts the procurement of Qiagen reagents for forensic science testing applications under the Fiscal Year 2026 budget cycle, managed by the Forensic Sciences division within the District of Columbia. This initiative is tied to laboratory operations requiring reliable molecular diagnostics reagents, likely supporting DNA analysis, sample preparation, or other forensic testing workflows essential to criminal investigations and evidence processing. While the solicitation number and procurement details are not yet available, the posting date indicates this is a future forecast with no set-aside provisions indicated, meaning the opportunity is open to all eligible vendors without geographic or size-based restrictions. The place of performance and organizational details remain unspecified, but the activity is centered within the District of Columbia’s forensic system, suggesting delivery and use will occur at state or local forensic laboratories. No point of contact information is provided at this stage, and the NAICS code, office address, and other typical contracting metadata are also absent, indicating this is an early-stage forecast meant for market research and vendor awareness. Interested suppliers should monitor the official DC contracting portal for future solicitations tied to this forecast, as detailed requirements, timelines, and ordering procedures will be released in subsequent procurement actions.
Forensic Sciences (DFS)

POSTED

about 3 hours ago

DEADLINE

N/A
View Details
NAICS: 325413
New
DIBBS
CALIBRATOR KIT, HAEMATOThe CALIBRATOR KIT, HAEMATOLOGY is a specialized reagent kit designed for calibrating UNICEL DXH COULTER cellular analysis systems used in hematology applications, with each unit containing 3.3 mL of calibrator. It is subject to strict technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, and must comply with DLA packaging standards including the Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item is classified as a Type I (Code A) shelf-life item with a non-extendable shelf life of one month, requiring that no more than four days pass between the date of manufacture and delivery to the government. All packaging must include the date of manufacture, expiration date, contract number, and lot number, in accordance with the latest revision of MMS1C. The calibrator must be stored and transported under refrigerated conditions between 2°C to 8°C (36°F to 46°F) and must not be frozen. Packaging must be commercial-grade, sealed, and designed to protect contents from damage during shipping, with exterior containers suitable for safe delivery via common carrier at the lowest cost. The product is associated with NSN 6550-01-625-1271 and is being procured under solicitation SPE2DS-26-T-262K, with a required delivery within five days after award, and bidders must clearly specify the source and part number being offered.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325413
New
DIBBS
TEST KIT, CHLORIDE DThis contract is for the procurement of TEST KIT, CHLORIDE D, specifically CHLORIDE QUANTAB TEST STRIPS rated for a high range of 300 to 6000 mg/L, supplied in quantities of 40 strips per bottle, with one bottle required. The item is identified by NSN 6550-01-722-0245 and is subject to strict technical and quality standards referenced from the DLA Master List of Technical and Quality Requirements, which govern its specification and compliance. The product must meet commercial packaging requirements as defined for medical acquisitions, including sealed unit containers to prevent damage and shipping containers suitable for safe transport at the lowest carrier rate. All packaging and marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and include mandatory labeling with the date of manufacture, expiration date, and contract or lot number in accordance with MMS1C. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed between the date of manufacture and delivery to the government. Delivery is required within 20 days after award, with performance addressed to Hampton, Virginia, under contract number SPE2DS-26-T-261X issued on July 22, 2026, with responses due by July 28, 2026. Bidders must provide the source and part number being offered, and the supply is subject to DLA packaging requirements and the potential application of covered defense information regulations. All items must be marked for government use and comply with procedures for removal of government identification from non-accepted supplies. The procurement is managed by the Department of Defense’s Medical Supply Chain under the office of Marc Canalichio, with full technical and logistical specifications enforced by DLA Troop Support.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 5 days
View Details